Propiedad y actividad de insiders de Eupraxia Pharmaceuticals Inc. (EPRX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $8.09 |
| Capitalización | $271M |
| Bolsa | NASDAQ |
| País | CA |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $4.0M | $823481 | $1.2M | $150126 | $20.9M | $24.7M | $14.6M | $33.1M | $80.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $9.0M | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $1.3M | $1.5M | 0 | 0 | 0 | 0 | $143516 | $228872 | $674226 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $5.5M | $2.5M | $2.6M | $1.1M | $30.6M | $25.2M | $14.9M | $34.4M | $85.1M |
| Inmovilizado Material | $419438 | $435468 | $646210 | $315337 | $589068 | $718608 | $343520 | $424916 | $987126 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $5.9M | $2.9M | $3.3M | $1.5M | $31.2M | $25.9M | $15.3M | $34.9M | $86.2M |
| Cuentas por Pagar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deuda a Corto | 0 | $3.8M | $11.6M | $12.5M | $94916 | $107528 | $7.8M | 0 | 0 |
| Pasivos Corrientes | $730683 | $14.3M | $20.7M | $22.5M | $2.3M | $4.1M | $14.6M | $3.1M | $5.6M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $9.7M | $11.9M | 0 | 0 | 0 |
| Pasivos Totales | $735815 | $14.3M | $21.4M | $23.1M | $12.1M | $16.1M | $14.6M | $3.1M | $5.7M |
| Reservas | -$20.1M | -$40.0M | -$47.2M | -$51.2M | -$74.3M | -$104.6M | -$79.4M | -$131.0M | -$169.6M |
| Patrimonio Neto | $6.0M | -$11.1M | -$17.7M | -$21.2M | $20.0M | $10.5M | $1.7M | $33.4M | $82.0M |
| Deuda Total | $12474 | $3.8M | $11.9M | $12.8M | $10.0M | $12.2M | $7.9M | $71859 | $154362 |
| Deuda Neta | -$4.0M | $3.0M | $10.8M | $12.6M | -$19.9M | -$12.6M | -$6.7M | -$33.0M | -$80.4M |
| Capital Circulante | $4.8M | -$11.9M | -$18.0M | -$21.4M | $28.3M | $21.0M | $323137 | $31.3M | $79.5M |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 16.00 |
Rentabilidad
| Rentabilidad sobre capital | -45.29% |
| Rentabilidad sobre capital invertido | -43.07% |
| Rentabilidad sobre activos | -35.72% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: AARD · GNFT · IVA · MDWD · NAUT · NTHI · OBIO
Explorar sector: Healthcare · Biotechnology
Más secciones de EPRX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones